ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents87,86576,896116,216206,492
Short Term Investments319,504199,344235,65198,680
Net Receivables----
Inventory--936-
Other Current Assets8,4399,20039,27416,287
Total Current Assets419,809287,254393,183322,201
Long Term Investments-22286575,840
Property, plant and equipment6,4005,6307,0761,974
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets3010,0308,03012
Deferred Long Term Asset Charges----
Total Assets426,239303,136409,154400,027
Current Liabilities
Accounts Payable8,9457,47110,3614,727
Short/Current Long Term Debt----
Other Current Liabilities74929262
Total Current Liabilities28,23623,36625,89012,372
Long Term Debt182,104---
Other Liabilities2,168495481138
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities212,50823,86126,37112,510
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock7754
Retained Earnings-963,938-667,509-378,630-222,376
Treasury Stock-1,056-92-48-501
Capital Surplus1,074,963946,869761,456610,390
Other Stockholder Equity-1,056-92-48-501
Total stockholders' equity109,976279,275382,783387,517
Net Tangible Assets109,976279,275382,783387,517